Redcare Pharmacy NV Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	956	1,324	2,679	2,395	798	2,050
Market Cap Growth	-59.06%	-50.57%	11.86%	200.06%	-61.07%	-22.87%
Enterprise Value	1,300	1,465	2,742	2,508	840	1,990
Last Close Price	46.10	65.65	132.90	130.00	45.92	113.30
PS Ratio	0.33	0.45	1.13	1.33	0.66	1.93
PB Ratio	2.00	2.76	5.25	4.34	2.25	4.93
P/TBV Ratio	14.55	20.16	36.85	25.46	12.16	12.98
P/FCF Ratio	-	-	199.93	43.53	-	-
P/OCF Ratio	30.84	42.72	121.23	38.97	-	176.21
EV/Sales Ratio	0.44	0.50	1.16	1.40	0.70	1.88
EV/EBITDA Ratio	27.20	732.56	-	173.30	-	-
EV/FCF Ratio	-26.92	-	204.64	45.59	-	-
Debt / Equity Ratio	0.87	0.87	0.49	0.44	0.66	0.55
Debt / EBITDA Ratio	45.28	45.28	-	11.75	-	-
Debt / FCF Ratio	-	-	18.45	4.43	-	-
Net Debt / Equity Ratio	0.45	0.45	0.14	0.07	0.16	-0.13
Net Debt / EBITDA Ratio	106.55	106.55	-4.10	2.74	-1.61	2.59
Net Debt / FCF Ratio	-4.41	-4.41	5.20	0.72	-1.28	25.65
Asset Turnover	2.65	2.65	2.34	2.05	1.59	1.61
Inventory Turnover	12.39	12.39	12.60	11.54	8.89	8.92
Quick Ratio	0.89	0.89	1.21	1.45	1.85	2.58
Current Ratio	1.55	1.55	2.00	2.23	2.88	3.49
Return on Equity (ROE)	-7.97%	-7.97%	-8.74%	-2.56%	-20.17%	-17.65%
Return on Assets (ROA)	-1.13%	-1.13%	-2.41%	-0.27%	-3.90%	-3.05%
Return on Capital Employed (ROCE)	-2.50%	-2.50%	-5.20%	-0.50%	-7.70%	-4.90%
Earnings Yield	-3.94%	-2.85%	-1.70%	-0.50%	-9.73%	-3.62%
FCF Yield	-5.05%	-3.65%	0.50%	2.30%	-5.35%	-0.11%
Buyback Yield / Dilution	-0.58%	-0.27%	-4.24%	-6.97%	-0.57%	-24.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.